Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early relapse after treatment. ...
Apr 18, 2024
0
4
For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal therapy alone, according ...
Apr 17, 2024
0
2
A review by the American College of Physicians (ACP) of performance measures designed to evaluate quality of care for those suffering from major depressive disorder found only 1 of 8 measures relevant to internal medicine ...
Mar 5, 2024
0
1
Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very poor prognosis. But clinical studies have shown that drugs called ...
Feb 8, 2024
0
0
Pancreatitis is inflammation of the pancreas, a long, flat gland that lies horizontally behind your stomach. The pancreas produces enzymes for digestion and hormones that regulate the way your body processes sugar.
Jan 31, 2024
0
1
Certain cancers are more difficult to treat because they contain cells that are highly skilled at evading drugs or our immune systems by disguising themselves as healthy cells.
Jan 11, 2024
0
32
Scientists at Nottingham Trent University wanted to investigate the anti-cancer properties of carnosine against cells derived from both primary and metastatic prostate cancer—where the cancer began and where it had spread ...
Jan 5, 2024
0
38
For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment, and this rate can be higher for patients with more advanced stages of the cancer. While ...
Dec 29, 2023
0
67
The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression two years after discontinuing treatment, ...
Dec 18, 2023
0
2
QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15%–20% of endometrial ...
Dec 13, 2023
0
0
